ReviewWorld journal of microbiology & biotechnology2017
Secondary metabolites of endophytic Xylaria species with potential applications in medicine and agriculture.
Review in World journal of microbiology & biotechnology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
34 citing papers in PubMed, 89 citations in OpenAlex.
- Mannosylxylarinols A and B, Two New 3,4-Seco-ergostane-type Steroidal Saponins From the Fungus Xylaria necrophora SZSS1-2-2.Chemistry & biodiversity · 2026Article
- The Influence of Wild Grapevine Endophytes on the Growth of the Model PlantLife (Basel, Switzerland) · 2026Article
- In Vitro Modeling of Mycelium Biomass Growth Kinetics of the Novel Fungicolous SpeciesJournal of fungi (Basel, Switzerland) · 2026Article
- Comparative Transcriptome Analysis ofMycobiology · 2026Article
- Phytochemical and bioactive insights into endophytic fungi from Wrightia tinctoria with emphasis on Xylaria rohrensis metabolites potential.Scientific reports · 2025Article
- Theabrownin combined with zearalenone suppresses colitis-associated colorectal cancer by inhibiting PI3K/AKT pathway and enhancing microbial propionate production.Scientific reports · 2025Article
- Xylariaides A and B, novel cytochalasans with a unique 5/6/5/3 ring system from a soil fungus Xylaria sp. Y01.Natural products and bioprospecting · 2025Article
- Nematicidal and antifeedant activity of ethyl acetate extracts from culture filtrates of Arabidopsis thaliana fungal endophytes.Scientific reports · 2025Article
- Biopesticide Compounds from an Endolichenic FungusMolecules (Basel, Switzerland) · 2025Article
- Carbon substrates utilization determine antagonistic fungal-fungal interactions among root-associated fungi.Frontiers in microbiology · 2025Article
- Advances on Bioactive Metabolites with Potential for the Biocontrol of Plant Pathogenic Bacteria.Pathogens (Basel, Switzerland) · 2024Review
- Multifaceted bioactivity of marine fungal derived secondary metabolite, xyloketal B -a review.Toxicology research · 2024Review
- The Cytochalasins and Polyketides from a Mangrove Endophytic FungusMarine drugs · 2024Article
- Diversity of Leaf Fungal Endophytes from TwoPlants (Basel, Switzerland) · 2024Article
- Structures and Biological Activities of Secondary Metabolites fromJournal of fungi (Basel, Switzerland) · 2024Review
- Antiproliferative polyketides from fungus Xylaria cf. Longipes SWUF08-81 in different culture media.Natural products and bioprospecting · 2024Article
- Antimicrobial Activity and Molecular Docking Studies of the Biotransformation of Diterpene Acanthoic Acid Using the FungusAntibiotics (Basel, Switzerland) · 2023Article
- Fascinating Furanosteroids and Their Pharmacological Profile.Molecules (Basel, Switzerland) · 2023Review
- Review
- Integracides: Tetracyclic Triterpenoids fromLife (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fungal endophytes are important sources of bioactive secondary metabolites. The genus Xylaria Hill (ex Schrank, 1789, Xylariaceae) comprises various endophytic species associated to both vascular and non vascular plants. The secondary metabolites produced by Xylaria species include a variety of volatile and non-volatile compounds. Examples of the former are sesquiterpenoids, esters, and alcohols, among others; and of the latter we find terpenoids, cytochalasins, mellein, alkaloids, polyketides, and aromatic compounds. Some of these metabolites have shown potential activity as herbicides, fungicides, and insecticides; others possess antibacterial, antimalarial, and antifungal activities, or α-glucosidase inhibitory activity. Thus metabolites from Xylaria are promising compounds for applications in agriculture for plague control as biopesticides, and biocontrol agents; and in medicine, for example as drugs for the treatment of infectious and non-infectious diseases. This review seeks to show the great value of the secondary metabolites of Xylaria, particularly in the agriculture and medicine fields.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.